Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02529813
Title CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute leukemia

chronic lymphocytic leukemia

acute lymphoblastic leukemia

CLL/SLL

non-Hodgkin lymphoma

Therapies

Cyclophosphamide + Fludarabine + Tisagenlecleucel

Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.